# Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Sep 28, 2019

- Company: [Thermo Fisher Scientific Inc.](/companies/tmo.md) (CIK 97745)
- Form: 10-Q
- Filed: 2019-11-01
- Accepted by EDGAR: Nov 1, 2019, 10:56 ET
- Period: 2019-09-28
- Accession: 0000097745-19-000049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97745/000009774519000049/q3201910q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97745/000009774519000049/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-28.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-06-30 to 2019-09-28 | $6.27bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-01-01 to 2019-09-28 | $18.71bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months, 2019-06-30 to 2019-09-28 | $247.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2019-01-01 to 2019-09-28 | $741.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-06-30 to 2019-09-28 | $1.54bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2019-01-01 to 2019-09-28 | $4.63bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-06-30 to 2019-09-28 | $946.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-28 | $3.36bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-06-30 to 2019-09-28 | $164.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-01-01 to 2019-09-28 | $534.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-06-30 to 2019-09-28 | $62.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-28 | $338.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-06-30 to 2019-09-28 | $760.0m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 9 months, 2019-01-01 to 2019-09-28 | $2.69bn | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2019-06-30 to 2019-09-28 | $1.88 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-28 | $6.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-06-30 to 2019-09-28 | $1.89 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-01-01 to 2019-09-28 | $6.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-06-30 to 2019-09-28 | 404,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-01-01 to 2019-09-28 | 403,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-28 | $3.06bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-28 | $637.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2019-01-01 to 2019-09-28 | $221.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2019-01-01 to 2019-09-28 | $750.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-09-28 | $1.27bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-28 | $10.51bn | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-28 | $56.73bn | us-gaap:Assets |
| Current liabilities | at 2019-09-28 | $5.84bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2019-09-28 | $16.39bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-09-28 | $661.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2019-09-28 | $29.36bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2019-09-28 | 400,991,227 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/97745/000009774519000049/q3201910q.htm

Filed Nov 1, 2019.
Source: SEC EDGAR, the filing index for accession 0000097745-19-000049. Last ingested by Listed: Nov 14, 2026, 12:05 ET. No prices; not investment advice.
